Transfer-pricing treatment of ITeS margins excludes pass-through tax recoveries and separate delayed-receivables interest after working-capital adjust...
Capacity-utilisation adjustments under TNMM can neutralise substantiated COVID-related idle costs where underutilisation materially affects profitabil...
TNMM functional comparability requires excluding rice manufacturers from a pure Basmati rice trader's benchmark and recognising operating export recei...
Working-capital adjustment subsumes delayed-receivable effects in TNMM benchmarking of captive software-development services, avoiding separate notion...
Transfer-pricing comparability requires exclusion of financially illogical super-profit comparables and correction of unsupported annual-report and ma...
Charitable character assessment preserves Section 80G approval despite inclusive spiritual teachings and incidental religious expenditure within the s...
Penalty proceedings for cash-loan acceptance require assessment proceedings and recorded Assessing Officer satisfaction; absent these, the proceedings...
Page of 4828
Press 'Enter' after typing page number.
161 to 180 of 96556 Results
❮
❯
❯❯
0 / 200
Expand Note
Add to Folder
No Folders have been created
+
Are you sure you want to delete "My most important" ?
The GoI's DGFT issued Notification No. 17/2025-26 amending export policy for Pharma Grade Sugar under Foreign Trade (Development & Regulation) Act 1992. The amendment introduces a new export regime permitting restricted export of Pharma Grade Sugar, with strict conditions: total annual exports capped at 25,000 MTs, mandatory submission of valid drug manufacturing license, and required NABL-accredited laboratory test reports confirming pharmaceutical grade specifications. Exporters must obtain Restricted Export Authorization, ensuring controlled and regulated pharmaceutical sugar exports while maintaining quality and quantity standards.
The GoI's DGFT issued Notification No. 17/2025-26 amending export policy for Pharma Grade Sugar under Foreign Trade (Development & Regulation) Act 1992. The amendment introduces a new export regime permitting restricted export of Pharma Grade Sugar, with strict conditions: total annual exports capped at 25,000 MTs, mandatory submission of valid drug manufacturing license, and required NABL-accredited laboratory test reports confirming pharmaceutical grade specifications. Exporters must obtain Restricted Export Authorization, ensuring controlled and regulated pharmaceutical sugar exports while maintaining quality and quantity standards.
Note: It is a system-generated summary and is for quick reference only.